Which biomarkers predict risk better in women? - Takeaways - MDSpire

Which biomarkers predict risk better in women?

  • By

  • Lale Tokgözoğlu

  • Meral Kayıkçıoğlu

  • October 29, 2025

  • 0 min

Share

  • 1

    Atherosclerotic cardiovascular disease is the leading cause of mortality among women, yet prevention relies on male-validated algorithms and biomarkers.

  • 2

    Women experience higher lifetime cardiovascular risk post-menopause due to atherogenic dyslipidemia, necessitating sex-specific risk factor recognition.

  • 3

    In a study of 866 high-risk patients, certain lipid biomarkers showed sex-specific predictive value for major cardiovascular events.

  • 4

    The omission of Lp(a) and non-HDL-C in the study limits comprehensive interpretation of lipid-based sex differences in cardiovascular risk.

  • 5

    Current evidence suggests ApoB or non-HDL-C should complement LDL-C for more accurate cardiovascular risk assessment in women.

Original Source(s)

Which biomarkers predict risk better in women?

  • by Lale Tokgözoğlu, Meral Kayıkçıoğlu

  • October 29, 2025

Related Content

High-fat diet-induced obesity impairs endothelium-dependent relaxation in rabbits: association with MLCK upregulation and partial ex vivo improvement by ML-7

Non-Invasive Techniques In Pediatric Dyslipidemia

Damon B. Dixon, MD, at Phoenix Children’s Cardiology, is the author to this EndoText chapter. Dr. Dixon brings nationally recognized expertise in pediatric cardiovascular risk assessment and non?invasive vascular imaging.

  • May 15, 2026

  • 1 min
Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes